Health
Doctis
DocTIS is a project that aims to improve treatment efficacy in six immune-mediated inflammatory diseases (IMIDs), including: Crohn's disease, ulcerative...

Magnetoelectric and ultrasonic technology for advanced brain modulation

Project dates
2024-2027
Website
Role of Zabala
Partner
Project led by
IDIBAPS
7
Partners
4
Countries
€3.8 M
Total budget
36
Months
Pathological alterations of neurological function, such as disorders of consciousness, stroke, epilepsy, depression, Parkinson’s Disease or traumatic brain injury, are commonly associated with alterations in brain rhythms and activity patterns. These neuropsychiatric diseases have the prevalence of 180 million people per year in the European Union and it is increasing every year. Consequently, there is a pressing clinical demand for treatments capable of accurately controlling and restoring neural activity.
META-BRAIN is dedicated to achieving precise control over brain activity patterns by employing two innovative strategies: magnetoelectric nanoparticles and ultrasound remote brain stimulation. In order to improve spatial resolution beyond current technologies, META-BRAIN will explore the use of cutting-edge nanotechnologies like graphene micro-transistors and advanced innovations such as capacitive micromachined ultrasonic transducers. These methods will be tested with biological samples using minimally invasive techniques.
META-BRAIN’s minimally invasive approaches could significantly impact the treatment of various prevalent medical conditions associated with altered electrical activity in neuronal tissue, such as consciousness disorders, stroke, epilepsy, depression, Parkinson’s Disease and traumatic brain injury. Also, META-BRAIN will generate high-quality novel insights and pave the way for advancements in the research and technology of stimulating brain tissue activity.


This project has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101130650.

“The innovative stimulation paradigm introduced by META-BRAIN shows promising potential in restoring normal brain activity, offering therapeutic prospects for millions of patients”
Carlos Alfaro
European Projects R&D and Innovation Consultant
Redefining Neuroscience: European project advances precise spatiotemporal control of brain activity for therapeutic purposes






Health
DocTIS is a project that aims to improve treatment efficacy in six immune-mediated inflammatory diseases (IMIDs), including: Crohn's disease, ulcerative...
Health
The main objective of SPIOMET4HEALTH is to test, in a multi-centre Phase II clinical trial, a novel treatment for adolescent...
Health
The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of two new clinical trials against...

News
The data published on Phase 2 of the LIFE 2018 call, confirm an impressive positioning for ZABALA: we comfortably double the average success in all areas of LIFE.

Opinion
HORIZON EUROPE

Javier Uranga
Entrepreneurship Consultant

Publication
Regions
Innovation is key to making regions more digital and sustainable, and in our publication you will learn about the funding opportunities that make this possible
Lo importante no es seguir avanzando, sino saber hacia dónde ir. Y nuestra tasa de éxito del 37% demuestra que en Zabala sabemos guiar a nuestros clientes.
Nuestra brújula es el cliente; nuestra misión es resolver sus problemas, guiándole para que la innovación se convierta en su clave de competitividad.
